Terry J Rosen Arcus Biosciences, Inc. (RCUS) insider trading activity

Terry J Rosen is Chief Executive Officer of Arcus Biosciences, Inc.. Currently has a direct ownership of 2.16 Million shares of RCUS, which is worth approximately $43.3 Million. The most recent transaction as insider was on Jan 08, 2026, when has been sold 35,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 2.16M

15.53% 3M change

8.95% 12M change

Total Value Held $43.3 Million

TERRY J ROSEN Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jan 08 2026	SELL Bona fide gift	-	35,000 Reduced 1.6%	2,157,409 Common Stock
Dec 30 2025	SELL Bona fide gift	-	2,400 Reduced 0.11%	2,192,409 Common Stock
Dec 17 2025	SELL Open market or private sale	$570,487 $22.16 p/Share	25,744 Reduced 1.16%	2,194,809 Common Stock
Dec 16 2025	SELL Open market or private sale	$633,360 $21.88 p/Share	28,947 Reduced 1.29%	2,220,553 Common Stock
Feb 27 2025	BUY Open market or private purchase	$201,564 $10.18 p/Share	19,800 Added 0.77%	2,554,160 Common Stock
Jan 23 2025	BUY Grant, award, or other acquisition	-	165,000 Added 6.11%	2,534,360 Common Stock
Dec 15 2024	SELL Payment of exercise price or tax liability	$609,142 $16.08 p/Share	37,882 Reduced 1.57%	2,369,360 Common Stock

Jun 15 2024	SELL Payment of exercise price or tax liability	$215,009 $16.97 p/Share	12,670 Reduced 0.32%	3,954,304 Common Stock
Jan 23 2024	BUY Grant, award, or other acquisition	-	100,000 Added 2.46%	3,966,974 Common Stock
Dec 29 2023	BUY Acquisition or disposition by will or laws	-	448 Added 0.01%	3,866,974 Common Stock
Dec 19 2023	SELL Sale (or disposition) back to the issuer	$253,260 $18.09 p/Share	14,000 Reduced 0.36%	3,866,526 Common Stock
Dec 18 2023	SELL Sale (or disposition) back to the issuer	$243,126 $17.74 p/Share	13,705 Reduced 0.35%	3,880,526 Common Stock
Jun 16 2023	SELL Sale (or disposition) back to the issuer	$169,544 $19.35 p/Share	8,762 Reduced 0.22%	3,894,231 Common Stock
Jan 23 2023	BUY Grant, award, or other acquisition	-	105,700 Added 18.39%	469,123 Common Stock
Dec 16 2022	SELL Open market or private sale	$403,680 $30.95 p/Share	13,043 Reduced 5.11%	242,173 Common Stock
Jun 17 2022	SELL Open market or private sale	$101,486 $22.0 p/Share	4,613 Reduced 1.99%	227,716 Common Stock
Jun 16 2022	SELL Open market or private sale	$87,874 $20.72 p/Share	4,241 Reduced 1.79%	232,329 Common Stock
Mar 08 2022	BUY Grant, award, or other acquisition	-	65,000 Added 19.03%	276,570 Common Stock
Dec 17 2021	SELL Open market or private sale	$118,044 $40.11 p/Share	2,943 Reduced 1.37%	211,570 Common Stock
Dec 16 2021	SELL Open market or private sale	$92,029 $40.03 p/Share	2,299 Reduced 1.06%	214,513 Common Stock
Jun 17 2021	SELL Open market or private sale	$115,156 $23.68 p/Share	4,863 Reduced 2.31%	205,562 Common Stock
Jun 16 2021	SELL Open market or private sale	$97,018 $24.45 p/Share	3,968 Reduced 1.85%	210,425 Common Stock
Jan 19 2021	BUY Grant, award, or other acquisition	-	45,000 Added 16.11%	234,393 Common Stock

Also insider at

IDYA

IDEAYA Biosciences, Inc. Healthcare

TJR

Terry J Rosen

Chief Executive Officer

Hayward, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RCUS shares.

Notify only if

Value

Insider Trading

Get notified when an Arcus Biosciences, Inc. insider buys or sells RCUS shares.

Notify only if

Operation

Value

Type

News

Receive news related to Arcus Biosciences, Inc.

Track Activities on RCUS

Account